Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Ashley Nych

Physician Assistant Roanoke, VA Physician Assistant

NPI 1265914378 CMS profile 10534964

2001 Crystal Spring Ave Sw, Ste 203, Roanoke, VA 24014

Open in the dashboard

General payments

$5,042

106 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ashley Nych of Roanoke, VA is reported in the CMS Open Payments database as having received $5,042 across 106 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $445 9
2024 General $2,559 32
2023 General $1,212 32
2022 General $292 18
2021 General $533 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ashley Nych
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Ashley Nych were reported at $445. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Ashley Nych Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $533 $132 $37–$438 $132
2022 $292 $155 $48–$522 $149
2023 $1,212 $167 $52–$557 $160
2024 $2,559 $178 $55–$600 $164
2025 $445 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $2,480 28 payments
  2. Medtronic, Inc. $1,245 63 payments
  3. iRhythm Technologies, Inc. $636 4 payments
  4. Abbott Laboratories $148 2 payments
  5. Abiomed $132 1 payment
  6. Genzyme Corporation $124 1 payment
  7. Novo Nordisk Inc $93 1 payment
  8. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $92 5 payments
  9. E.R. Squibb & Sons, L.L.C. $91 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,780 103 payments
  2. Travel and Lodging $1,262 3 payments
Products named General payments · program years 2021–2025
  1. ZIO XT Patch $636 4 payments
  2. COBALT DR MRI SURESCAN $372 19 payments
  3. Micra $224 10 payments
  4. LINQ II $210 9 payments
  5. Zio monitor $191 1 payment
  6. SelectSecure $177 7 payments
  7. SARCLISA $124 1 payment
  8. LUX-Dx Insertable Cardiac Monitor $121 8 payments
  9. EMBLEM MRI S-ICD $109 2 payments
  10. ACCOLADE SR $108 1 payment
  11. Other $820 37 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 21 drugs

Part D claims

906

Median for Physician Assistant: 241

Drug cost

$232,090

Median for Physician Assistant: $4,110

Branded share of claims

39.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 199 $172,382
Entresto Sacubitril/Valsartan Brand 36 $32,367
Xarelto Rivaroxaban Brand 14 $13,300
Dofetilide Generic 69 $8,075
Flecainide Acetate Generic 56 $1,154
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 60 $1,113
Metoprolol Succinate Generic 129 $729
Bumetanide Generic 13 $460
Sotalol Sotalol Hcl Brand 25 $350
Amiodarone Hcl Generic 42 $313

The 10 drugs with the highest cost, of 21 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$6,620

Medicare's payments for the services billed

Medicare patients

133

Average age 78

Services billed

227

64 women, 69 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 71%
Arthritis 59%
Ischemic heart disease 55%
Heart failure 53%
Chronic kidney disease 41%
Diabetes 38%
Depression 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

106 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record